Kearns & Associates LLC Invests $219,000 in UnitedHealth Group Incorporated (NYSE:UNH)

by · The Cerbat Gem

Kearns & Associates LLC bought a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 375 shares of the healthcare conglomerate’s stock, valued at approximately $219,000.

A number of other large investors have also recently made changes to their positions in UNH. WFA Asset Management Corp grew its position in shares of UnitedHealth Group by 44.0% during the 1st quarter. WFA Asset Management Corp now owns 265 shares of the healthcare conglomerate’s stock valued at $131,000 after purchasing an additional 81 shares in the last quarter. China Universal Asset Management Co. Ltd. increased its stake in UnitedHealth Group by 20.6% in the 1st quarter. China Universal Asset Management Co. Ltd. now owns 10,867 shares of the healthcare conglomerate’s stock worth $5,376,000 after acquiring an additional 1,857 shares during the last quarter. KFA Private Wealth Group LLC boosted its position in shares of UnitedHealth Group by 3.4% during the 1st quarter. KFA Private Wealth Group LLC now owns 2,807 shares of the healthcare conglomerate’s stock valued at $1,389,000 after acquiring an additional 92 shares during the last quarter. Janney Capital Management LLC raised its stake in UnitedHealth Group by 20.0% in the first quarter. Janney Capital Management LLC now owns 26,489 shares of the healthcare conglomerate’s stock valued at $13,104,000 after purchasing an additional 4,416 shares in the last quarter. Finally, Resonant Capital Advisors LLC lifted its holdings in shares of UnitedHealth Group by 20.5% during the 1st quarter. Resonant Capital Advisors LLC now owns 2,045 shares of the healthcare conglomerate’s stock worth $1,012,000 after acquiring an additional 348 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $567.56 on Friday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.88 and a current ratio of 0.91. The company has a 50 day simple moving average of $581.96 and a two-hundred day simple moving average of $541.50. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $608.63. The company has a market capitalization of $524.10 billion, a price-to-earnings ratio of 36.97, a P/E/G ratio of 1.66 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH – Get Free Report) last released its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. The business had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. UnitedHealth Group’s revenue was up 9.2% compared to the same quarter last year. During the same period last year, the business earned $6.56 EPS. Analysts expect that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.48%. The ex-dividend date was Monday, September 16th. UnitedHealth Group’s payout ratio is presently 54.72%.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on UNH shares. HSBC lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, October 17th. Wells Fargo & Company increased their price target on shares of UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a research report on Wednesday, July 17th. Truist Financial reaffirmed a “buy” rating and issued a $625.00 price objective (down previously from $640.00) on shares of UnitedHealth Group in a research note on Wednesday, October 16th. KeyCorp initiated coverage on shares of UnitedHealth Group in a research note on Friday, October 11th. They issued an “overweight” rating and a $675.00 price target for the company. Finally, Bank of America decreased their price objective on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. Four equities research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $615.53.

View Our Latest Research Report on UnitedHealth Group

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles